COPD heterogeneity: Gender differences in the multidimensional BODE index

International Journal of COPD

Volumn 2, Issue 2, 2007, Pages 151-155

  de Torres, Juan P ^a,c   Casanova, Ciro ^a   de Garcini, Angela Montejo ^a   Jaime, Armando Aguirre ^a   Celli, Bartolomé R ^b  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b Caritas St Elizabeth Health System   (United States)

^c Respiratory Research Unit   (Spain)

Author keywords

BODE index; COPD; Gender

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODE INDEX; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PHYSICAL CAPACITY; PREDICTOR VARIABLE; PROGNOSIS; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; WALKING;

AGE FACTORS; AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; WALKING;

EID: 34547623081     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agustí AGN, Noguera A, Sauleda J, et al. 2003. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J, 21:347-60.
2. Anthonisen NR, Wright EC, Hodgkin JE. 1986. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis, 133:14-20.
3. [ATS] ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. 2002. ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 166:111-17.
4. Brooks SM. 1982. Surveillance for respiratory hazards. ATS News, 8:12-16.
5. Celli BR, Calverley PM, Rennard SI, et al. 2005. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med, 99:1546-54.
6. Celli BR, Cote CG, Marin JM, et al. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350:1005-12.
7. Cote CG, Celli BR. 2005. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J, 26:630-6.
8. de Torres JP, Casanova C, Hernandez C, et al. 2005. Gender and COPD in patients attending a pulmonary clinic. Chest, 128:2012-16.
9. Imfeld S, Bloch KE, Weder W, et al. 2006. The BODE index after lung volume reduction surgery correlates with survival. Chest, 129:873-8.
10. Mannino DM, Homa DM, Akinbami LJ, et al. 2002. Chronic pulmonary disease surveillance - United States, 1971-2000. Respir Care, 47:1184-99.
11. Murray CJL, Lopez AD. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349:1269-76
12. Nishimura K, Izumi T, Tsukino M, et al. 2002. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest, 121:1434-40.
13. Pinto-Plata VM, Cote C, Cabral, et al. 2004. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J, 23:28-33.
14. Quanjer PH. 1983. Standardized lung function testing. Report of the Working Party for the European Community for Steel and Coal. Bull Eur Physiopath Respir, 19(supp 5):22-7.
15. Ries AL, Kaplan RM, Blumberg E. 1991. Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease. J Clin Epidemiol, 44:497-503.
16. Siafakas NM, Vermeire P, Pride NB, et al; on behalf of the Task Force. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J, 8:1398-420.
17. Troosters T, Gosselink R, Decramer M. 1999. Six minute walking distance in healthy elderly subjects. Eur Respir J, 14:270-4.
18. Vestbo J, Prescott E, Almdal T, et al. 2005. Body mass, fat free body mass and prognosis in COPD patients from a random population sample. Am J Respir Crit Care Med, Sep 15: [Epub].